» Articles » PMID: 31434491

Mechanism of Enhanced MerTK-Dependent Macrophage Efferocytosis by Extracellular Vesicles

Overview
Date 2019 Aug 23
PMID 31434491
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Extracellular vesicles secreted by cardiosphere-derived cells (CDC) polarize macrophages toward a distinctive phenotype with enhanced phagocytic capacity (M). These changes underlie cardioprotection by CDC and by the parent CDCs, notably attenuating the no-reflow phenomenon following myocardial infarction, but the mechanisms are unclear. Here, we tested the hypothesis that M are especially effective at scavenging debris from dying cells (ie, efferocytosis) to attenuate irreversible damage post-myocardial infarction. Approach and Results: In vitro efferocytosis assays with bone marrow-derived macrophages, and in vivo transgenic rodent models of myocardial infarction, demonstrate enhanced apoptotic cell clearance with M. CDC exposure induces sustained MerTK expression in M through extracellular vesicle transfer of microRNA-26a (via suppression of ); the cardioprotective response is lost in animals deficient in MerTK. Single-cell RNA-sequencing revealed phagocytic pathway activation in M, with increased expression of complement factor , a phagocytosis facilitator.

Conclusions: Together, these data demonstrate that extracellular vesicle modulation of MerTK and C1qa expression leads to enhanced macrophage efferocytosis and cardioprotection.

Citing Articles

Extracellular vesicular microRNAs and cardiac hypertrophy.

Hu H, Wang X, Yu H, Wang Z Front Endocrinol (Lausanne). 2025; 15():1444940.

PMID: 39850481 PMC: 11753959. DOI: 10.3389/fendo.2024.1444940.


Big data analytics and scRNA-seq in human aortic aneurysms and dissections: role of endothelial MerTK.

Liu S, Wu J, Banerjee O, Xue B, Shi H, Ding Z Theranostics. 2025; 15(1):202-215.

PMID: 39744231 PMC: 11667232. DOI: 10.7150/thno.103851.


The immune regulatory role of exosomal miRNAs and their clinical application potential in heart failure.

Guo D, Yan J, Yang Z, Chen M, Zhong W, Yuan X Front Immunol. 2024; 15:1476865.

PMID: 39687609 PMC: 11647038. DOI: 10.3389/fimmu.2024.1476865.


Efferocytosis: the resolution of inflammation in cardiovascular and cerebrovascular disease.

Zhang B, Zou Y, Yuan Z, Jiang K, Zhang Z, Chen S Front Immunol. 2024; 15:1485222.

PMID: 39660125 PMC: 11628373. DOI: 10.3389/fimmu.2024.1485222.


Deconstructing Regenerative Medicine: From Mechanistic Studies of Cell Therapy to Novel Bioinspired RNA Drugs.

Marban E Circ Res. 2024; 135(8):877-885.

PMID: 39325847 PMC: 11469554. DOI: 10.1161/CIRCRESAHA.124.323058.


References
1.
Ishimoto Y, Ohashi K, Mizuno K, Nakano T . Promotion of the uptake of PS liposomes and apoptotic cells by a product of growth arrest-specific gene, gas6. J Biochem. 2000; 127(3):411-7. DOI: 10.1093/oxfordjournals.jbchem.a022622. View

2.
Taylor P, Carugati A, Fadok V, Cook H, Andrews M, Carroll M . A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med. 2000; 192(3):359-66. PMC: 2193213. DOI: 10.1084/jem.192.3.359. View

3.
Scott R, McMahon E, Pop S, Reap E, Caricchio R, Cohen P . Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature. 2001; 411(6834):207-11. DOI: 10.1038/35075603. View

4.
Lois C, Hong E, Pease S, Brown E, Baltimore D . Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science. 2002; 295(5556):868-72. DOI: 10.1126/science.1067081. View

5.
Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S . Identification of a factor that links apoptotic cells to phagocytes. Nature. 2002; 417(6885):182-7. DOI: 10.1038/417182a. View